Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Healthcare providers are unfamiliar with LDL-C targets and how to implement therapeutic regimens to achieve treatment goals in rural patient populations. Healthcare providers lack familiarity with the role of elevated Lp(a) as a risk factor for ASCVD and how to target elevated Lp(a) in rural settings.

image
 

Complete Your Profile

Please complete your profile if you haven’t already, even if you have signed in with LinkBlue. Click the button below or go to "My Account" and then click "Edit" and then "Profile" to fill in the required information to ensure accurate reporting of your credits. Be sure to add all of your Board certification and licenses, if applicable. You can type your board name in the field to make adding them easier.

image
 

Saving Souls: Alzheimer's Outreach

Alzheimer’s disease (AD) disproportionately affects certain populations due to social determinants of health, yet most clinicians lack sufficient knowledge of the latest diagnostic tools and disease-modifying therapies that can help mitigate these disparities. This timely activity is designed to address these gaps with real-world, practical approaches for busy clinicians.

image
 

Tackling Obesity in Appalachian Healthcare: Approaches, Challenges, and Solutions

Appalachia faces significant healthcare challenges, particularly in rural and underserved areas where access to primary and preventive care remains limited. These regions consistently rank among the lowest in national health metrics, with high rates of chronic conditions like diabetes, heart disease, and obesity, necessitating comprehensive and accessible healthcare services.

image

tackling-obesity
 
Pause

Live courses

There is currently no content to view in this section.

Recent courses

  • Enduring
TTRansforming Amyloidosis Care in Kentucky (Enduring)
  • Cardiology
  • Internal Medicine
Needs StatementOften mistaken for more common heart failure, cardiac amyloidosis is a rare and serious disease that requires an accurate diagnosis and prompt treatment.
0
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE
    • 1.00 ANCC (UK Healthcare CECentral)
    • 1.00 Participation
  • Enduring
Drug Conviction Data in KASPER: What is a Prescriber to Do?
  • Addiction Medicine
Kentucky State Senate Bill 32 (2017) mandated that drug conviction data be made available in KASPER effective July
0
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC (UK Healthcare CECentral)
    • 1.50 Participation
    • 1.50 Dentistry/KDA
Prescriber and Pharmacist Resources
0

Pages